← All cap tiers
Cap tier

Micro Cap

Every analyzed stock in Micro Cap — 3,138 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
Sort by: A–Z Most overvalued Most shorted Buyers' strike Largest
PTORW
Praetorian Acquisition Corp.
Valuation N/A
Financial Services
Price$0.25
Model IV—
P/IV—
Limited data — see page
PTY
PIMCO CORPORATE & INCOME OPPORTUNITY FUND
Valuation N/A
Unknown
Price$10.97
Model IV—
P/IV—
Limited data — see page
PULM
Pulmatrix, Inc.
Valuation N/A
Healthcare
Price$1.46
Model IV—
P/IV—
Market implies -10.8%/yr vs model +15.0% · below model
PUSA
Aureus Greenway Holdings Inc
Valuation N/A
Communication Services
Price$2.59
Model IV—
P/IV—
Market implies +51.9%/yr
PVL
Permianville Royalty Trust
Valuation N/A
Energy
Price$1.79
Model IV—
P/IV—
Limited data — see page
PW
Power REIT
Deeply overvalued
Financial Services
Price$6.95
Model IV$1.49
P/IV4.60
Premium +366% Return to IV: -78.5%
PWRL
Powerlaw Corp.
Valuation N/A
Unknown
Price$11.85
Model IV—
P/IV—
Limited data — see page
PXLW
PIXELWORKS, INC
Valuation N/A
Technology
Price$5.94
Model IV—
P/IV—
Market implies +65.6%/yr
PXS
Pyxis Tankers Inc.
Fairly valued
Industrials
Price$7.79
Model IV$6.83
P/IV0.98
Premium +14% Return to IV: -12.4%
Market implies -3.9%/yr vs model -2.4% · in line
PYPD
PolyPid Ltd.
Valuation N/A
Healthcare
Price$5.07
Model IV—
P/IV—
Limited data — see page
PYT
PPLUS Trust Series GSC-2
Valuation N/A
Financial Services
Price$23.22
Model IV—
P/IV—
Limited data — see page
PYXS
Pyxis Oncology, Inc.
Valuation N/A
Healthcare
Price$2.03
Model IV—
P/IV—
Market implies +20.7%/yr
PZG
Paramount Gold Nevada Corp.
Valuation N/A
Basic Materials
Price$1.16
Model IV—
P/IV—
Market implies +39.3%/yr vs model +5.0% · above model
QADR
QDRO Acquisition Corp.
Valuation N/A
Financial Services
Price$10.01
Model IV—
P/IV—
Limited data — see page
QADRU
QDRO Acquisition Corp.
Valuation N/A
Financial Services
Price$10.10
Model IV—
P/IV—
Limited data — see page
QADRW
QDRO Acquisition Corp.
Valuation N/A
Financial Services
Price$0.24
Model IV—
P/IV—
Limited data — see page
QCLS
Q/C TECHNOLOGIES, INC.
Valuation N/A
Healthcare
Price$0.63
Model IV—
P/IV—
Limited data — see page
QETA
Quetta Acquisition Corp
Valuation N/A
Financial Services
Price$16.41
Model IV—
P/IV—
Limited data — see page
QETAR
Quetta Acquisition Corp
Valuation N/A
Financial Services
Price$0.80
Model IV—
P/IV—
Limited data — see page
QETAU
Quetta Acquisition Corp
Valuation N/A
Financial Services
Price$13.40
Model IV—
P/IV—
Limited data — see page
QMCO
QUANTUM CORP /DE/
Deeply overvalued
Technology
Price$30.43
Model IV$23.05
P/IV0.42
Premium +32% Return to IV: -24.2%
Market implies +8.7%/yr vs model +2.0% · above model
QNCX
Quince Therapeutics, Inc.
Valuation N/A
Healthcare
Price$31.73
Model IV—
P/IV—
Limited data — see page
QNTM
Quantum Biopharma Ltd.
Valuation N/A
Healthcare
Price$2.94
Model IV—
P/IV—
Limited data — see page
QQQX
Nuveen NASDAQ 100 Dynamic Overwrite Fund
Valuation N/A
Unknown
Price$31.10
Model IV—
P/IV—
Limited data — see page
QRED
QuasarEdge Acquisition Corp
Valuation N/A
Financial Services
Price$10.05
Model IV—
P/IV—
Limited data — see page
QRHC
Quest Resource Holding Corp
Deeply overvalued
Utilities
Price$1.38
Model IV$0.38
P/IV3.15
Premium +268% Return to IV: -72.8%
QSEA
Quartzsea Acquisition Corp
Valuation N/A
Financial Services
Price$10.71
Model IV—
P/IV—
Limited data — see page
QSEAR
Quartzsea Acquisition Corp
Valuation N/A
Financial Services
Price$0.25
Model IV—
P/IV—
Limited data — see page
QSEAU
Quartzsea Acquisition Corp
Valuation N/A
Financial Services
Price$10.80
Model IV—
P/IV—
Limited data — see page
QSI
Quantum-Si Inc
Valuation N/A
Healthcare
Price$1.53
Model IV—
P/IV—
Market implies +88.3%/yr vs model +15.0% · above model
QSIAW
QSIAW
Valuation N/A
Price$0.20
Model IV—
P/IV—
Limited data — see page
QTEX
QTREX Quantum Ltd.
Valuation N/A
Healthcare
Price$1.87
Model IV—
P/IV—
Market implies +91.0%/yr vs model +15.0% · above model
QTI
QT IMAGING HOLDINGS, INC.
Undervalued
Healthcare
Price$2.68
Model IV$3.80
P/IV1.32
Discount 29% Return to IV: +41.8%
Market implies -12.2%/yr vs model +15.0% · below model
QTRX
Quanterix Corp
Deeply overvalued
Healthcare
Price$3.28
Model IV$1.33
P/IV2.38
Premium +147% Return to IV: -59.6%
Market implies +12.8%/yr vs model +5.9% · above model
QTTB
Q32 Bio Inc.
Fairly valued
Healthcare
Price$8.34
Model IV$9.47
P/IV1.17
Discount 12% Return to IV: +13.5%
Market implies -10.1%/yr vs model +12.2% · below model
QUCY
Quantum Cyber N.V.
Valuation N/A
Healthcare
Price$1.35
Model IV—
P/IV—
Market implies +70.9%/yr
QUIK
QUICKLOGIC Corp
Valuation N/A
Technology
Price$10.85
Model IV—
P/IV—
Market implies +50.2%/yr
QUMS
Quantumsphere Acquisition Corp
Valuation N/A
Financial Services
Price$10.35
Model IV—
P/IV—
Limited data — see page
QUMSR
Quantumsphere Acquisition Corp
Valuation N/A
Financial Services
Price$0.09
Model IV—
P/IV—
Limited data — see page
QUMSU
Quantumsphere Acquisition Corp
Valuation N/A
Financial Services
Price$10.38
Model IV—
P/IV—
Limited data — see page
QXL
QUANTUM X LABS INC.
Valuation N/A
Technology
Price$3.93
Model IV—
P/IV—
Market implies -8.3%/yr vs model +15.0% · below model
RA
Brookfield Real Assets Income Fund Inc.
Valuation N/A
Unknown
Price$11.54
Model IV—
P/IV—
Limited data — see page
RAAQ
RAAQ
Valuation N/A
Price$13.42
Model IV—
P/IV—
Limited data — see page
RAAQU
RAAQU
Valuation N/A
Price$13.00
Model IV—
P/IV—
Limited data — see page
RAAQW
RAAQW
Valuation N/A
Price$5.10
Model IV—
P/IV—
Limited data — see page
RAC
Rithm Acquisition Corp.
Valuation N/A
Financial Services
Price$10.57
Model IV—
P/IV—
Limited data — see page
RACC
Research Alliance Corp III
Valuation N/A
Healthcare
Price$10.18
Model IV—
P/IV—
Limited data — see page
RAIL
FreightCar America, Inc.
Deeply undervalued
Consumer Cyclical
Price$6.25
Model IV$15.69
P/IV0.48
Discount 60% Return to IV: +151.1%
Market implies -0.5%/yr vs model +20.5% · below model
RAIN
Rain Enhancement Technologies Holdco, Inc.
Valuation N/A
Industrials
Price$0.67
Model IV—
P/IV—
Limited data — see page
RAINW
Rain Enhancement Technologies Holdco, Inc.
Valuation N/A
Industrials
Price$0.17
Model IV—
P/IV—
Limited data — see page
RAND
RAND CAPITAL CORP
Deeply undervalued
Unknown
Price$10.02
Model IV$78.60
P/IV0.13
Discount 87% Return to IV: +684.4%
Market implies -26.6%/yr vs model +6.0% · below model
RANG
Range Capital Acquisition Corp.
Valuation N/A
Financial Services
Price$10.88
Model IV—
P/IV—
Limited data — see page
RANGR
Range Capital Acquisition Corp.
Valuation N/A
Financial Services
Price$0.25
Model IV—
P/IV—
Limited data — see page
RANGU
Range Capital Acquisition Corp.
Valuation N/A
Financial Services
Price$11.32
Model IV—
P/IV—
Limited data — see page
RANI
Rani Therapeutics Holdings, Inc.
Valuation N/A
Healthcare
Price$0.80
Model IV—
P/IV—
Limited data — see page
RAVE
RAVE RESTAURANT GROUP, INC.
Undervalued
Consumer Defensive
Price$2.30
Model IV$3.07
P/IV0.90
Discount 25% Return to IV: +33.4%
Market implies -2.6%/yr vs model +6.1% · below model
RAY
Raytech Holding Ltd
Deeply overvalued
Consumer Cyclical
Price$2.63
Model IV$1.19
P/IV2.36
Premium +122% Return to IV: -54.9%
Market implies +10.4%/yr vs model +15.0% · below model
RAYA
Erayak Power Solution Group Inc.
Valuation N/A
Technology
Price$1.71
Model IV—
P/IV—
Limited data — see page
RBKB
Rhinebeck Bancorp, Inc.
Deeply overvalued
Financial Services
Price$12.86
Model IV$9.15
P/IV1.78
Premium +40% Return to IV: -28.8%
RBNE
Robin Energy Ltd.
Deeply undervalued
Industrials
Price$2.23
Model IV$3.93
P/IV0.60
Discount 43% Return to IV: +76.2%
Market implies -16.9%/yr vs model +2.0% · below model